Uncomplicated Urinary Tract Infection caused by susceptible bacteria

Drug	Drug Name	Drug Description
DB01137	Levofloxacin	A fluoroquinolone antibiotic used to treat infections caused by susceptible bacteria of the upper respiratory tract, skin and skin structures, urinary tract, and prostate, as well as for post-exposure treatment of inhaled anthrax and the plague.
DB00440	Trimethoprim	An antifolate antibiotic often used in combination with sulfamethoxazole to treat a number of infections, including those of the urinary tract, respiratory tract, and gastrointestinal tract.

Drug	Drug Name	Target	Type
DB01137	Levofloxacin	DNA gyrase subunit A	target
DB01137	Levofloxacin	DNA topoisomerase 4 subunit A	target
DB01137	Levofloxacin	Solute carrier family 22 member 2	transporter
DB01137	Levofloxacin	P-glycoprotein 1	transporter
DB01137	Levofloxacin	Solute carrier family 22 member 4	transporter
DB01137	Levofloxacin	Multidrug and toxin extrusion protein 1	transporter
DB01137	Levofloxacin	Multidrug and toxin extrusion protein 2	transporter
DB01137	Levofloxacin	Cytochrome P450 2C9	enzyme
DB01137	Levofloxacin	Serum albumin	carrier
DB01137	Levofloxacin	Solute carrier organic anion transporter family member 4C1	transporter
DB01137	Levofloxacin	Solute carrier family 22 member 1	transporter
DB01137	Levofloxacin	Solute carrier organic anion transporter family member 1A2	transporter
DB00440	Trimethoprim	Dihydrofolate reductase	target
DB00440	Trimethoprim	Cytochrome P450 2C8	enzyme
DB00440	Trimethoprim	Cytochrome P450 3A4	enzyme
DB00440	Trimethoprim	P-glycoprotein 1	transporter
DB00440	Trimethoprim	Cytochrome P450 2C9	enzyme
DB00440	Trimethoprim	Cytochrome P450 1A2	enzyme
DB00440	Trimethoprim	Multidrug and toxin extrusion protein 1	transporter
DB00440	Trimethoprim	Multidrug and toxin extrusion protein 2	transporter

Drug	Drug Name	Phase	Status	Count